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Abstract
Background: The aim of the present study was to assess the performance of three primary care-led initiatives
providing structured care to patients with Type 2 diabetes in Ireland, a country with minimal incentives to
promote the quality of care.
Methods: Data, from three primary care initiatives, were available for 3010 adult patients with Type 2 diabetes.
Results were benchmarked against the national guidelines for the management of Type 2 diabetes in the
community and results from the National Diabetes Audit (NDA) for England (2008/2009) and the Scottish Diabetes
Survey (2009).
Results: The recording of clinical processes of care was similar to results in the UK however the recording of
lifestyle factors was markedly lower. Recording of HbA1c, blood pressure and lipids exceeded 85%. Recording of
retinopathy screening (71%) was also comparable to England (77%) and Scotland (90%). Only 63% of patients had
smoking status recorded compared to 99% in Scotland while 70% had BMI recorded compared to 89% in England.
A similar proportion of patients in this initiative and the UK achieved clinical targets. Thirty-five percent of patients
achieved a target HbA1c of < 6.5% (< 48 mmol/mol) compared to 25% in England. Applying the NICE target for
blood pressure (≤ 140/80 mmHg), 54% of patients reached this target comparable to 60% in England. Slightly less
patients were categorised as obese (> 30 kg/m
2) in Ireland (50%, n = 1060) compared to Scotland (54%).
Conclusions: This study has demonstrated what can be achieved by proactive and interested health professionals
in the absence of national infrastructure to support high quality diabetes care. The quality of primary care-led
diabetes management in the three initiatives studied appears broadly consistent with results from the UK with the
exception of recording lifestyle factors. The challenge facing health systems is to establish quality assurance a
responsibility for all health care professionals rather than the subject of special interest for a few.
Background
The ability of a health system to deliver effective dia-
betes care reflects a system’s wider capacity to manage
other chronic diseases [1,2]. The management of
chronic conditions such as diabetes requires planned,
structured care which is integrated in the wider health
system [3]. Enhancing the structure and coordination of
care within and between settings has been shown to
improve the quality of care for patients with diabetes
[4,5]. As a result there is growing emphasis internation-
ally and nationally on system, practice and professional-
level initiatives to improve the quality of care.
In Ireland, care is delivered in a variety of ways to
patients with diabetes including traditional mixed care,
hospital-led care, shared care arrangements and primary
care-led management. At general practice level, care is
often ad-hoc reflected in the absence of patient regis-
tries, irregular review and the lack of guideline use
among General Practitioners (GPs) [6]. Access to essen-
tial support services such as retinopathy screening is
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any medium, provided the original work is properly cited.variable and inconsistent with multiple providers of ser-
vices often influenced by whether a patient is attending
the public or private health system.
Within this opportunistic system, there are a number
of ‘islands of excellence’ providing comprehensive sys-
tematic care for patients with diabetes. Among these
groups are three primary care initiatives involving inter-
ested trained professionals aiming to improve the quality
of care and patient outcomes. The initiatives seek to
develop a multidisciplinary structured approach to dia-
betes care delivery. Adopting a structured approach to
care delivery involves continuing professional education,
incorporating guidelines, creating practice registers and
ongoing audit and feedback for participating practices.
Specialist input is provided in one initiative by a dia-
betes nurse specialist while the other two initiatives are
coordinated by a diabetes nurse facilitator. Participating
practices also receive administrative and audit/research
support to manage the initiatives.
The aim of this study was to assess the quality of care
provided by three primary care-led initiatives adopting a
structured approach to Type 2 diabetes care in Ireland,
benchmarked against national guidelines and diabetes
audit results observed in England and Scotland. The
quality of care was assessed in terms of processes of dia-
betes care and intermediate outcomes of care. Diabetes
care delivery in the UK is supported by an infrastructure
including a dedicated policy framework, a retinopathy
screening programme, robust IT systems in general
practice and a financial incentive structure to promote
quality assurance. With this in mind we hypothesized
that a group of ‘champions’ with a special interest in
diabetes would have a performance comparable to that
observed in the UK.
Methods
Study design, setting and selection of participants
This cross sectional study was based on data from pri-
mary care-based diabetes initiatives across three regions
of Ireland; the Diabetes Interest Group Cork (DIG) in
the South of Ireland, the HSE Midland Diabetes Struc-
tured Care Programme and HSE North East Diabetes
Watch. Each initiative provides structured care to
patients with diabetes in the general practice setting
with some patients also attending secondary care.
Sample
Practices
A purposive sample of three primary care initiatives par-
ticipated in this study. Three of the most well-estab-
lished schemes were chosen, all of which conducted and
disseminated regular audit. There are currently ten dia-
betes initiatives in Ireland however most did not engage
in routine audit at the time. Although a purposive
sample of schemes was used, within each scheme all
practices took part in the audit (n = 63). The sample
represents nearly 1%of the total number of GPs in
Ireland.
Participating practices were from a mixture of urban
and rural areas and included single-handed and group
practices. All practices provided structured care to
patients in the general practice setting which involved
continuing professional education, incorporating guide-
lines, maintaining practices registers and engaging in
regular audit and feedback. Each practice employed a
Practice Nurse. Specialist input was provided in one
initiative by a Diabetes Nurse Specialist while the other
two initiatives were coordinated by a Diabetes Nurse
Facilitator. Practices also received administrative and
audit/research support to manage the initiatives. Two of
the three initiatives financially reimbursed practices for
their involvement in the scheme.
Patients
Adult patients (≥ 18 years of age) with Type 2 diabetes,
who were registered with a participating practice on
their electronic practice register were eligible for inclu-
sion in the analysis. Type 2 diabetes was defined on the
basis of standard clinical and blood glucose criteria [7].
Patients with Type 1 diabetes and Pre-diabetes were
excluded from the analysis as the care of these patients
is not part of routine audit in all three initiatives.
In the Diabetes Interest Group all patients with Type
2 diabetes registered with participating practices were
included in the audit. In the Diabetes Watch pro-
gramme, all patients who attended the GP for their 2
nd
diabetes visit were included in the audit. Due to the
large number of patients enrolled on the HSE Midland
Diabetes Structured Care Programme (> 3000 patients)
a random sample was selected from each practice and
included in the overall analysis. The sample size was cal-
culated using glycaemic control (HbA1c level) as the
outcome measure with a confidence level of 95% and a
d i f f e r e n c eo f2 % .I nap r e v i o u sa u d i t ,t h em e a nH b A 1 c
for the total sample was 7.6% and the 95% confidence
interval was ± 0.111% which equates to ~1.5%. A sample
size calculator returned an estimated sample size of
1,168 (51.3% of the total sample). Data were available on
989 patients with Type 2 diabetes (47.1% of total sam-
ple) which was 97 patients less than the determined
sample size as a number of patients recorded on the
database as current and active had died, left the practice
or had been transferred to a nursing home.
Prevalence
Data were available for 3,010 patients with Type 2 dia-
betes from 63 practices. It was not possible to calculate
the prevalence of Type 2 diabetes in this sample as it is
not mandatory in Ireland for patients to register with a
single general practice therefore we lack a reliable
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each of the three regions in which the initiatives are
based, (4.3% Dublin North Leinster, 4.4% Dublin Mid-
Leinster, 4.9% Southern region) was comparable with
the estimated national prevalence (4.6%) [8] and the pre-
valence of Type 2 diabetes in Scotland (4.4%) and Eng-
land (4.1%).
Data Collection
The study was based on secondary data analysis of
anonymised data which had previously been published
and disseminated in individual audit reports from each
of the three initiatives therefore ethical approval was not
sought for the collated secondary analysis. The data was
originally collected for the purpose of service evaluation
which did not require patient consent.
Data were collected during 2008/2009 by Diabetes
Clinical Nurse Specialists in the Midlands region, by a
Diabetes Nurse Facilitator in the South, and in the
North East region datasheets were completed and sub-
mitted by the practices themselves. Data sources
included patient’s clinical notes (electronic and paper),
letters regarding hospital outpatient appointment and
referrals to other services (chiropody/podiatry, retinopa-
thy, dietetics etc). Table 1 shows details of variables col-
lected across all three initiatives.
The national guidelines for Type 2 diabetes care in the
community were used to define the optimal standard of
care in Ireland [7]. The guidelines outline the appropri-
ate processes of care involved in diabetes management,
set targets for the achievement of intermediate out-
comes and specify the relevant cut-off points which are
included in the text throughout the results section. In
addition HbA1c levels were broken down according to
the risk categorisation proposed by the Irish College of
General Practitioner Guidelines [9]. BMI results were
categorised according to the WHO cut-off points [10].
Comparisons were drawn with the National Diabetes
Audit of England for the corresponding period of 2008/
2009. This is the largest annual audit of diabetes services
in the world with over 1.5 million people with diabetes
included, 75% of the diabetic population. All primary
care trusts in England (N = 152) contributed data from
71% of GP practices (N = 5920) [11]. The NDA 2008/
2009 data are contained on the NDA “Dashboard”
w h e r ed a t aa r en o tb r o k e nd o w nb yt y p eo fd i a b e t e s .
The published report contains some results stratified by
type and where available figures for Type 2 diabetes are
used. Data from the National Diabetes Audit of Wales
were excluded from this study as results were based on
data from 31% of practices in Wales and therefore were
not considered representative.
Results were also compared to the Scottish Diabetes
Survey, a population level survey published annually by
the Scottish Diabetes Survey Monitoring Group. It col-
lates nationally agreed data submitted by 14 NHS
Boards in Scotland incorporating both primary and sec-
ondary care. Diabetes registers, held by each health
board, are the main source of data for the survey. In
2009 over 220,000 people were included in the survey,
of whom 87.4% had Type 2 diabetes. Results from 2009
were chosen as data were stratified by type of diabetes
allowing for direct comparison with Type 2 diabetes
management. Data on recording and outcomes were
similar across the 2008 and 2009 Scottish Diabetes Sur-
vey [12].
Statistical Analysis
Statistical analyses were undertaken using SPSS 16
(SPSS Inc., Chicago, IL, USA). Categorical data are pre-
sented as frequencies and percentage. Data are mean
+/- SD for continuous variables. Between-group analysis
of continuous variables was performed by an indepen-
dent t-test. Categorical variables were analysed using the
Pearson chi square test. A number of continuous vari-
ables were stratified into risk categories according to the
national and international guidelines. There were miss-
ing data on a number of variables ranging from 6% non-
Table 1 Common dataset across three primary care-led diabetes initiatives
Demographics Process of care Intermediate Outcome of Care
Gender Recording of HbA1c HbA1c
Age Recording of Blood Pressure Blood Pressure
Recording of Body Mass Index Body Mass Index (BMI)
Recording of Total Cholesterol concentration Total Cholesterol concentration
Recording of LDL Cholesterol concentration LDL Cholesterol concentration
Recording of HDL Cholesterol concentration HDL Cholesterol concentration
Recording of smoking status Smoking Status
Retinopathy screening in past year
Foot Assessment in the past year
Treatment with statin/aspirin
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Where this occurs, the figures represent the recorded
data.
Results
Characteristics of the study participants
The profile of patients was similar to that reported in
the National Diabetes Audit for England and the Scot-
tish Diabetes Survey. Of the 3,010 patients, 56.5% were
male (n = 1,701) (gender unknown for 0.4% of the sam-
ple, n = 11) comparable to 54.6% of males with diabetes
in Scotland. Data on the gender breakdown of patients
included in the NDA for England were not available.
The mean age of patients in this sample was 65.7
years (SD = 12.2). Over half of patients were aged 65
years or over (56.5%, n = 1691) compared to 70% of
patients in Scotland. Twenty-five percent of the people
included in the National Diabetes Audit for England
were < 40 years old. There was a statistically significant
age difference between males and females in this sample
(64.7 vs. 67.1, p < 0.001).
Recording Processes of Care
Process of care recording for clinical outcomes com-
pared favourably to results from the National Diabetes
Audit (NDA) for England and Wales, and the Scottish
Diabetes Survey (Table 2). Recording for retinopathy
screening (71%) was also similar to England and Wales
(69%) and Scotland (80%). However recording was
lower for body mass index (BMI) (70.4% vs. 90%) and
foot screening (64.6% vs. 78.8% in Scotland). Only two
of the three primary care initiatives collected informa-
tion on the recording of smoking status. Among these
practices (n = 1995), smoking status was recorded for




T h em e a nH b A 1 cv a l u ef o rt h es a m p l ew a s7 . 1 %( 5 4
mmol/mol) (SD = 1.3) with no statistically significant
difference in glycaemic control between males and
females (p = 0.795). There was a significant relationship
between the age of patients and glycaemic control (p <
0.01).
The mean HbA1c for patients with Type 2 diabetes
across the 14 NHS Boards in Scotland was marginally
higher (7.3% or 56 mmol/mol). Over one third of
patients with Type 2 diabetes (35%, n = 943) reached
the national recommended target for HbA1c (< 6.5% or
< 48 mmol/mol), compared to 25% of patients with dia-
betes in England. Approximately 72% of patients had an
HbA1c of < 7.5% (n = 1949) compared to 63.8% of
patients with Type 2 diabetes in Scotland. Table 3 illus-
trates the stratification of patients into three risk cate-
gories for HbA1c levels.
Blood Pressure
The mean systolic blood pressure for patients was 136.3
mmHg (SD = 16.6) with no significant difference
between males and females (p = 0.786). Applying the
cut-off of ≤ 140 mmHg for systolic blood pressure from
the Scottish Diabetes Survey, 69% of patients in Ireland
achieved this target compared to 74.6% of patients in
Scotland. The mean diastolic blood pressure was 77.2
mmHg (SD = 9.3). Again there was no significant differ-
ence between males and females (p = 0.373). Seventy-
two percent of patients (n = 1980) reached the national
recommended target for diastolic blood pressure of ≤ 80
mmHg. Comparable data on diastolic blood pressure
were not available from England or Scotland.
Thirty-seven percent of patients reached the recom-
mended target for blood pressure in Ireland (≤ 130/80
mmHg). There was a significant association between
Table 2 Recording of process measures in practices compared to England, and Scotland.
Three select primary care
initiatives in Ireland
National Diabetes Audit England 2008/09 Scotland 2009 Type 2 DM %
% (n) 95% CI % %
HbA1c 90.2*(2714) 89.0-91.2 91.7 89.9
Blood Pressure 93.5 (2814) 92.5-94.3 94.1 95
Total Cholesterol 92.2 (2776) 91.2-93.2 90.3 87.7
LDL Cholesterol 86.5 (2604) 85.2-87.7 - -
HDL Cholesterol 84.9 (2554) 83.5-86.1 - -
Smoking Status (n = 1995) 63.3 (1263) 61.5-65.4 86.8 99.3
BMI 70.4 (2119) 68.7-72.0 89.2 90.0
Retinopathy Screening (n = 2629) 71.2 (1872) 69.4-72.9 77.3 80.0
Foot Assessment (n = 2292) 64.6 (1481) 62.6-66.6 82.9 78.8
*4 patients with HbA1c = 0.1 were removed from analysis
†Data from the National Diabetes Audit dashboard represent Type 1 and Type 2 diabetes combined.
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the age category of patients (p < 0.001) (Figure 1). More
patients in the younger age category (18-40) reached the
target of ≤ 130/80 mmHg compared to the other age
groups: 18-40 (43.8%), 40-64 (34.6%), 65-84 (33.3%) and
85+ (30.5%). The target in the UK in 2008-2009 was ≤
140/80 for patients without eye, kidney or vascular dis-
ease. Applying this target 54.4% of patients in this sam-
ple reached the target compared to 60.2% of patients
with Type 2 diabetes in England.
Lipid Profile
The mean total cholesterol concentration for the group
was 4.2 mmol/L (SD = 1.0). The mean LDL cholesterol
concentration was 2.3 mmol/L (SD = 0.81) and the
mean HDL cholesterol concentration was 1.2 mmol/L
(SD = 0.36). Table 4 outlines the percentage of patients
achieving national targets for total cholesterol, LDL
cholesterol and HDL cholesterol. Using the Pearson chi
square test, there were significant associations between
gender and achievement of lipid targets (p < 0.001) and
between patients’ age category and the achievement of
lipid targets (p < 0.001). Figure 1 illustrates the achieve-
ment of targets among the different age categories.
Fifty-seven percent of patients from the primary care
initiatives in Ireland achieved the UK total cholesterol
target of < 4 mmol/l compared to 73.2% of patients
with Type 2 diabetes in England
Smoking
Smoking status was recorded in two of the three struc-
tured care initiatives (n = 1995) (Diabetes Interest
Group, DIG and HSE Midland Area Diabetes Structured
Care Programme). Within the two groups, smoking sta-
tus was recorded for 63% of patients (n = 1263) com-
pared to 87% recording in England and almost complete
Table 3 Patients categorized according to risk categories for HbA1c levels [9].
Three select primary care initiatives in Ireland % (n = 2718) National Diabetes Audit* England Scotland** (%)




Medium Risk (6.5 - 7.5%)
(48-59 mmol/mol)
37.0 (1006) 37.8
High Risk (> 7.5%)
(> 59 mmol/mol)
28.3 (769) 37.2% 36.1
*National Diabetes Audit data represent Type 1 and Type 2 diabetes combined
**Scottish Diabetes Survey: HbA1c was categorised as < 7.5, (7.5-9.0) and > 9.0.
Figure 1 Achievement of outcomes by age category.
Mc Hugh et al. BMC Health Services Research 2011, 11:348
http://www.biomedcentral.com/1472-6963/11/348
Page 5 of 9recording in Scotland (99.3%). Just over 1 in 5 people,
who had their smoking status documented, were
recorded as smokers (22.2%). There was no statistically
significant difference between males and females (p =
0.364) (males = 22.9%, females = 20.8%). A similar
smoking prevalence of 18.8% was reported in Scotland.
Body Mass Index (BMI)
The mean BMI of patients was 30.8 kg/m
2 (SD = 6.1),
above the national target of < 25 kg/m
2 [7]. There was
no statistically significant difference between males and
females (30.6 kg/m
2 vs. 31.1 kg/m
2, p = 0.082). Fifty-
percent of patients with Type 2 diabetes (n = 1060)
were in the obese category (> 30 kg/m
2) compared to
54.4% of patients with Type 2 diabetes in Scotland (Fig-
ure 2).
Discussion
The quality of primary care-led diabetes management
This study has demonstrated what can be achieved by
proactive and interested health professionals in the
absence of a national infrastructure to support diabetes
management. There was a high level of recording of
intermediate clinical outcomes such as HbA1c and
blood pressure, comparable to results in the UK. How-
ever the recording of lifestyle factors such as BMI and
smoking status was markedly lower. Similar proportions
of patients in Ireland and the UK were achieving targets
for HbA1c, cholesterol and blood pressure. Over one
third of patients reached the national target for glycae-
mic control (HbA1c < 6.5%) compared to one quarter of
patients in the National Diabetes Audit for England
(NDA). The proportion of patients meeting the UK
blood pressure target (≤ 135/75 mmHg) was also similar
to results in the National Diabetes Audit however it was
less than 30% of patients in both instances. Half of all
the patients were categorized as obese (> 30 kg/m
2),
similar to findings in Scotland.
T h ee x i s t e n c eo ft h eQ u a l i t yO u t c o m e sF r a m e w o r k
(QOF) in the UK goes some way towards explaining the
high level of process recording found in the National
Diabetes Audit and the Scottish Diabetes Survey. How-
ever the proportion of patients in Ireland achieving tar-
gets for intermediate outcomes was similar to UK
results, despite the lack of a comparable national incen-
tive structure to improve the quality of care. This is in
keeping with the suggestion that it is easier to improve
the recording of care, which is under the control of the
health professional, without necessarily making a signifi-
cant impact on patient outcomes [13,14].
The Role of Special Interest
The quality of care demonstrated by practices in this
study highlights the contribution of special interest to
the management of chronic diseases. The concept of
special interest is a driver of quality assurance in the
primary care initiatives as practice staff participate
voluntarily in ongoing audit and feedback, a process
hindered by the lack of stable and robust IT systems for
routine data capture such as those available in Scotland
[15]. The role of GPs with special interests has been for-
malized in the UK as part of the reconfiguration of ser-
vices within the NHS to improve the accessibility, free
up specialist hospital services and reduce waiting times
[16,17]. It is also envisaged that GPs with special inter-
ests would take referrals from other GPs [18]. Evalua-
tion of this policy direction is limited however the
scheme has been piloted in the field of dermatology
whereby a GP with a special interest achieved similar
clinical outcomes to the hospital-based service, was
more accessible and preferred by patients [19] although
the cost of providing the specialist service in general
practice was higher [20]. In Ireland formal specialisation
is limited to nursing staffa tp r e s e n tw i t hc a l l sf o r
increasing numbers of Diabetes Nurse Specialists to
facilitate the reorientation and reorganisation of diabetes
care [21].
Isolating the Improvement Factor
It is important to note that the essential ingredient for
improving diabetes care has not been isolated. A recent
review of systematic reviews of diabetes care pro-
grammes also failed to find conclusive evidence of the
critical components of diabetes management pro-
grammes [22]. A number of studies have highlighted the
positive impact of enhancing organisation and physician
behaviour through multidimensional interventions
[4,23]. Practices involved in these primary care initia-
tives have introduced a number of organizational and
professional strategies, including patient registers and
ongoing audit, which have been shown to be effective in
improving delivery and outcome of care [4,24]. The
search for the single × factor in quality improvement
Table 4 Lipid profile of patients compared to national targets and comparing males and females.
Recommended Target Three select primary-Care Initiatives in Ireland % Males vs. Females (%) P value
Blood Pressure ≤ 130/80 mmHg 37% 33.6% vs. 34.5% p = 0.35
Total Cholesterol < 4.5 mmol/l 64.5% 69.8% vs. 56.6% P < 0.001
LDL Cholesterol < 2.5 mmol/l 64.2% 68.2% vs. 58.9% P < 0.001
HDL Cholesterol > 1.0 mmol/l 70.9% 62.6% v 82.0% P < 0.001
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tion and improvement may be a result of the synergy
between different approaches [25]. Research has now
begun to look towards what are the common features of
high quality care. One common feature among the three
initiatives involved in this study is the involvement of a
nurse who is dedicated solely to supporting the delivery
of evidence based diabetes care in the community.
Strengths and Limitations
This study is limited in its comparisons by the dearth of
information on the quality of diabetes care across Eur-
ope. It should be stressed that this study is not a com-
parison of ‘like with like’ but rather a benchmark of the
performance of a select group of special interest prac-
tices providing structured care in Ireland against the
standard of care observed in countries supported by a
national diabetes management infrastructure. Further-
more the results of this study are not typical of diabetes
care in Ireland. The lack of routine data collection in
Ireland prohibited the inclusion of a reference group of
practices not participating in initiatives delivering struc-
tured care.
This study focuses on the group-level performance of
GPs involved in primary care diabetes initiatives how-
ever data on practice characteristics such as age and
length in practice, which could influence the quality of
care, were not available for analysis in this study. Future
research should examine practice characteristics such as
case load and staff levels which could discriminate
between levels of performance within this group of
interested GPs. The absence of an agreed core dataset
for diabetes also limited the potential of the study as it
was not possible to combine all data collected by the
three initiatives. While data on long-term complications
were available from two of the three groups, data collec-
tion has yet to be standardised and these outcomes are
often not recorded consistently by all GPs involved. The
overemphasis on intermediate outcomes measured in
the short-term may underestimate the true effect of
quality improvement interventions which have yet to be
realised [26]. Data on long-term outcomes will
Figure 2 Percentage of patients in each BMI category.
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extent of the impact of structured care and whether
benefits have been sustained.
Conclusions
This study highlights the quality of care that can be
achieved by a group of proactive health professionals
working together to provide evidence based care in the
community in a system with minimal incentives. The
recording of processes of care was similar to the UK
with the exception of recording lifestyle factors, and
similar proportions of patients achieved clinical targets.
Primary care initiatives are a viable option for health
systems trying to tackle the growing burden of diabetes
care but we cannot presume or rely on special interest
to improve the quality of care for all patients. The chal-
lenge facing health systems is to establish quality assur-
ance as a responsibility for all health care professionals
rather than the subject of special interest for a few.
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